D. W. Nebert

发表

Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population.

A. Brøgger, D. Ryberg, V. Skaug, 1991, Pharmacogenetics.

Nonallelism for the audiogenic seizure prone (Asp1) and the aryl hydrocarbon receptor (Ahr) loci in mice.

T. Seyfried, T. Dalton, D. W. Nebert, 1998, Journal of neurogenetics.

Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect.

C. Zhang, F. Yang, E. Xu, 1991, Pharmacogenetics.

Importance of the route of administration for genetic differences in benzo[a]pyrene-induced in utero toxicity and teratogenicity.

C. Legraverend, T. Guenthner, D. W. Nebert, 1984, Teratology.

Comparison of beta-naphthoflavone and 3-methylcholanthrene as inducers of hepatic cytochrome(s) P-448 and aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity.

A. Boobis, J. Felton, D. W. Nebert, 1977, Molecular pharmacology.

Association between ornithine decarboxylase induction and the Ah locus in mice treated with polycyclic aromatic compounds.

J. Perry, T. Oka, D. W. Nebert, 1980, The Journal of biological chemistry.

The Ah phenotype. Survey of forty-eight rat strains and twenty inbred mouse strains.

H. Shinozuka, T. Gill, H. Kunz, 1982, Genetics.

Aryl hydrocarbon hydroxylase induction in retinal pigmented epithelium: possible association of genetic differences in a drug-metabolizing enzyme system with retinal degeneration.

H. Shichi, D. W. Nebert, Y. Tsunematsu, 1976, Experimental eye research.

Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama.

A. Kong, T. D. Arias, L. Jorge, 1991, Pharmacogenetics.

Bone marrow toxicity induced by oral benzo[a]pyrene: protection resides at the level of the intestine and liver.

D. Harrison, C. Legraverend, F. Ruscetti, 1983, Toxicology and applied pharmacology.

Relationship between "aromatic hydrocarbon responsiveness" and the survival times in mice treated with various drugs and environmental compounds.

S. Thorgeirsson, D. Nebert, R. Levitt, 1975, Molecular pharmacology.

The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases.

H. Gelboin, D. W. Nebert, N. M. Jensen, 1979, CRC critical reviews in biochemistry.

Genetic differences in the aromatic hydrocarbon-inducible n-hydroxylation of 2-acetylaminofluorene and acetaminophen-produced hepatotoxicity in mice.

S. Thorgeirsson, D. Nebert, J. Felton, 1975, Molecular pharmacology.

ARYL HYDROCARBON HYDROXYLASE INDUCTION IN CELL CULTURE AS A FUNCTION OF GENE EXPRESSION GENE EXPRESSION

D. Nebert, L. Bausserman, D. W. Nebert, 1971, Annals of the New York Academy of Sciences.

Differing degrees of coal-tar shampoo-induced mutagenesis in the Salmonella/liver test system in vitro.

L. Pohl, L. S. Andrews, L. Andrews, 1980, Pharmacology.

Effect of 17‐β‐estradiol and testosterone on aryl hydrocarbon hydroxylase activity in mouse tissues in vivo and in cell culture

R. Bates, L. Bausserman, D. W. Nebert, 1970, International journal of cancer.

Effects of harman and norharman on the mutagenicity and binding to DNA of benzo[a]pyrene metabolites in vitro and on aryl hydrocarbon hydroxylase induction in cell culture.

O. Pelkonen, R. Levitt, C. Legraverend, 1977, Biochemical and biophysical research communications.

Importance of genetic factors influencing the metabolism of foreign compounds.

J. Felton, D. W. Nebert, 1976, Federation proceedings.

Toxic chemical depression of the bone marrow and possible aplastic anemia explainable on a genetic basis.

R. Levitt, J. Felton, D. W. Nebert, 1980, Clinical toxicology.

Polycyclic hydrocarbon‐produced toxicity, transformation, and chromosomal aberrations as a function of aryl hydrocarbon hydroxylase activity in cell cultures

W. Benedict, D. Nebert, J. Gielen, 1972, International journal of cancer.

Human P45IA1 upstream regulatory sequences expressing the chloramphenicol acetyltransferase gene. Effect of Ha-MSV enhancer and comparison of transient with stable transformation assays.

D. Nebert, A. Jaiswal, D. W. Nebert, 1987, Biochemical and biophysical research communications.

Comparison of human mouse P1450 upstream regulatory sequences in liver- and nonliver-derived cell lines.

D. Nebert, F. Gonzalez, F. Gonzalez, 1987, Molecular endocrinology.

CYP2D1 polymorphism in methamphetamine-treated rats: genetic differences in neonatal mortality and effects on spatial learning and acoustic startle.

C. Vorhees, G. Cappon, J. Fisher, 1998, Neurotoxicology and teratology.

Refining the mouse chromosomal location of Cdm, the major gene associated with susceptibility to cadmium-induced testicular necrosis.

M. Miller, T. Dalton, R. McKinnon, 2000, Pharmacogenetics.

Cultured mouse embryos metabolize benzo[a]pyrene during early gestation: genetic differences detectable by sister chromatid exchange.

R. Pedersen, S. Galloway, J. Meneses, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Evidence for the activation of 3-methylcholanthrene as a carcinogen in vivo and asa mutagen in vitro by P1 -450 from inbred strains of mice.

J. Felton, D. W. Nebert, 1975, Advances in experimental medicine and biology.

THE Ah LOCUS. GENETIC DIFFERENCES IN TOXIC AND TUMORIGENIC RESPONSE TO FOREIGN COMPOUNDS

D. W. Nebert, 1980 .

Benzo[a]pyrene-initiated leukemia in mice. Association with allelic differences at the Ah locus.

D. W. Nebert, N. M. Jensen, 1979, Biochemical pharmacology.

Genetic differences in 2-acetylaminofluorene mutagenicity in vitro associated with mouse hepatic aryl hydrocarbon hydroxylase activity induced by polycyclic aromatic compounds.

S. Thorgeirsson, J. Felton, D. W. Nebert, 1976, Molecular pharmacology.

Mutagenesis of certain activated carcinogens in vitro associated with genetically mediated increases in monooxygenase activity and cytochrome P 1-450.

J. Felton, D. W. Nebert, 1975, The Journal of biological chemistry.

Effect of vitamin C deficiency during postnatal development on adult behavior: functional phenotype of Gulo(−/−) knockout mice

C. Vorhees, D. Nebert, C. Curran, 2012, Genes, brain, and behavior.

Evolutionary pharmacogenetics of CYP2D6 in Ngawbe Guaymi of Panama: allele-specific PCR detection of the CYP2D6B allele and RFLP analysis.

M. Eichelbaum, T. D. Arias, L. Jorge, 1993, Pharmacogenetics (London).

Genetic differences in benzo[a]pyrene-initiated tumorigenesis in mouse skin.

C. Legraverend, J. M. Holland, D. W. Nebert, 1980, Pharmacology.

Genetic differences in spatial learning between Dark Agouti and Sprague-Dawley strains: possible correlation with the CYP2D2 polymorphism in rats treated neonatally with methamphetamine.

C. Vorhees, G. Cappon, L. Morford, 1999, Pharmacogenetics.

The Ah locus: biochemical basis for genetic differences in brain tumor formation in mice.

R. Levitt, D. W. Nebert, N. M. Jensen, 1979, Genetics.

Genetic differences in the metabolic activation of benzo[a]pyrene in mice. Attempts to correlate tumorigenesis with binding of reactive intermediates to DNA and with mutagenesis in vitro.

A. Boobis, R. E. Kouri, O. Pelkonen, 1979, Pharmacology.

Ah locus: genetic differences in susceptibility to cataracts induced by acetaminophen.

D. Gaasterland, H. Shichi, D. W. Nebert, 1978, Science.

Genetic differences in cataract and other ocular abnormalities induced by paracetamol and naphthalene.

M. Tanaka, H. Shichi, D. W. Nebert, 1980, Pharmacology.

Human P-450 genes: evolution, regulation and possible role in carcinogenesis.

U. Meyer, D. W. Nebert, A. Jaiswal, 1987, Biochemical Society transactions.

Analysis of two benzo[a]pyrene‐resistant mutants of the mouse hepatoma Hepa‐1 P(1)450 gene via cDNA expression in yeast.

O. Hankinson, D. Nebert, S. Kimura, 1987, The EMBO journal.